#BEGIN_DRUGCARD DB02776

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
15015-81-3

# ChEBI_ID:
32912

# Chemical_Formula:
C16H34O3S

# Chemical_IUPAC_Name:
hexadecane-1-sulfonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-Hexadecanosulfonic Acid

# HET_ID:
HDS

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C16H34O3S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(17,18)19/h2-16H2,1H3,(H,17,18,19)

# InChI_Key:
InChIKey=SSILHZFTFWOUJR-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2776

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
306.504

# Molecular_Weight_Mono:
306.222865644

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1LPO

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
4.03

# Predicted_LogS:
-5.5

# Predicted_Water_Solubility:
8.57e-04 g/l

# Primary_Accession_No:
DB02776

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
14253

# PubChem_Substance_ID:
46504870

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01716

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCCCCCCCCCCS(O)(=O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:28 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Involved in hydrolase activity

# Drug_Target_1_General_References:
11061974	De Simone G, Galdiero S, Manco G, Lang D, Rossi M, Pedone C: A snapshot of a transition state analogue of a novel thermophilic esterase belonging to the subfamily of mammalian hormone-sensitive lipase. J Mol Biol. 2000 Nov 10;303(5):761-71.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4819

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34303

# Drug_Target_1_Name:
Hydrolase

# Drug_Target_1_Number_of_Residues:
310

# Drug_Target_1_PDB_ID:
1QZ3

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF07859	Abhydrolase_3

# Drug_Target_1_Protein_Sequence:
>Hydrolase
MPLDPVIQQVLDQLNRMPAPDYKHLSAQQFRSQQSLFPPVKKEPVAEVREFDMDLPGRTL
KVRMYRPEGVEPPYPALVYYHGGGWVVGDLETHDPVCRVLAKDGRAVVFSVDYRLAPEHK
FPAAVEDAYDALQWIAERAADFHLDPARIAVGGDSAGGNLAAVTSILAKERGGPALAFQL
LIYPSTGYDPAHPPASIEENAEGYLLTGGMMLWFRDQYLNSLEELTHPWFSPVLYPDLSG
LPPAYIATAQYDPLRDVGKLYAEALNKAGVKVEIENFEDLIHGFAQFYSLSPGATKALVR
IAEKLRDALA

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q7SIG1

# Drug_Target_1_SwissProt_Name:
Q7SIG1_ALIAC

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
4.85

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X64703

# Drug_Target_2_GenBank_ID_Protein:
1325987

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
LIP1

# Drug_Target_2_Gene_Sequence:
>1650 bp
ATGGAGCTCGCTCTTGCGCTCCTGCTCATTGCCTCGGTGGCTGCTGCCCCCACCGCCACG
CTCGCCAACGGCGACACCATCACCGGTCTCAACGCCATCATCAACGAGGCGTTCCTCGGC
ATTCCCTTTGCCGAGCCGCCGGTGGGCAACCTCCGCTTCAAGGACCCCGTGCCGTACTCC
GGCTCGCTCGATGGCCAGAAGTTCACGCTGTACGGCCCGCTGTGCATGCAGCAGAACCCC
GAGGGCACCTACGAGGAGAACCTCCCCAAGGCAGCGCTCGACTTGGTGATGCAGTCCAAG
GTGTTTGAGGCGGTGCTGCCGCTGAGCGAGGACTGTCTCACCATCAACGTGGTGCGGCCG
CCGGGCACCAAGGCGGGTGCCAACCTCCCGGTGATGCTCTGGATCTTTGGCGGCGGGTTT
GAGGTGGGTGGCACCAGCACCTTCCCTCCCGCCCAGATGATCACCAAGAGCATTGCCATG
GGCAAGCCCATCATCCACGTGAGCGTCAACTACCGCGTGTCGTCGTGGGGGTTCTTGGCT
GGCGACGAGATCAAGGCCGAGGGCAGTGCCAACGCCGGTTTGAAGGACCAGCGCTTGGGC
ATGCAGTGGGTGGCGGACAACATTGCGGCGTTTGGCGGCGACCCGACCAAGGTGACCATC
TTTGGCGAGCTGGCGGGCAGCATGTCGGTCATGTGCCACATTCTCTGGAACGACGGCGAC
AACACGTACAAGGGCAAGCCGCTCTTCCGCGCGGGCATCATGCAGCTGGGGGCCATGGTG
CCGCTGGACGCCGTGGACGGCATCTACGGCAACGAGATCTTTGACCTCTTGGCGTCGAAC
GCGGGCTGCGGCAGCGCCAGCGACAAGCTTGCGTGCTTGCGCGGTGTGCTGAGCGACACG
TTGGAGGACGCCACCAACAACACCCCTGGGTTCTTGGCGTACTCCTCGTTGCGGTTGCTG
TACCTCCCCCGGCCCGACGGCGTGAACATCACCGACGACATGTACGCCTTGGTGCGCGAG
GGCAAGTATGCCAACATCCCTGTGATCATCGGCGACCAGAACGACGAGGGCACCTTCTTT
GGCACCCTGCTGTTGAACGTGACCACGGATGCCCAGGCCCGCGAGTACTTCAAGCAGCTG
TTTGTCCACGCCAGCGACGCGGAGATCGACACGTTGATGACGGCGTACCCCGGCGACATC
ACCCAGGGCCTGCCGTTCGACACGGGTATTCTCAACGCCCTCACCCCGCAGTTCAAGAGA
ATCCTGGCGGTGCTCGGCGACCTTGGCTTTACGCTTGCTCGTCGCTACTTCCTCAACCAC
TACACCGGCGGCACCAAGTACTCATTCCTCCTGAAGCAGCTCCTGGGCTTGCCGGTGCTC
GGAACGTTCCACTCCAACGACATTGTCTTCCAGGACTACTTGTTGGGCAGCGGCTCGCTC
ATCTACAACAACGCGTTCATTGCGTTTGCCACGGACTTGGACCCCAACACCGCGGGGTTG
TTGGTGAAGTGGCCCGAGTACACCAGCAGCCTGCAGCTGGGCAACAACTTGATGATGATC
AACGCCTTGGGCTTGTACACCGGCAAGGACAACTTCCGCACCGCCGGCTACGACGCGTTG
TTCTCCAACCCGCCGCTGTTCTTTGTGTAA

# Drug_Target_2_General_Function:
Lipid transport and metabolism

# Drug_Target_2_General_References:
1610906	Longhi S, Fusetti F, Grandori R, Lotti M, Vanoni M, Alberghina L: Cloning and nucleotide sequences of two lipase genes from Candida cylindracea. Biochim Biophys Acta. 1992 Jun 15;1131(2):227-32.
2506450	Kawaguchi Y, Honda H, Taniguchi-Morimura J, Iwasaki S: The codon CUG is read as serine in an asporogenic yeast Candida cylindracea. Nature. 1989 Sep 14;341(6238):164-6.
8142346	Grochulski P, Bouthillier F, Kazlauskas RJ, Serreqi AN, Schrag JD, Ziomek E, Cygler M: Analogs of reaction intermediates identify a unique substrate binding site in Candida rugosa lipase. Biochemistry. 1994 Mar 29;33(12):3494-500.
8509417	Grochulski P, Li Y, Schrag JD, Bouthillier F, Smith P, Harrison D, Rubin B, Cygler M: Insights into interfacial activation from an open structure of Candida rugosa lipase. J Biol Chem. 1993 Jun 15;268(17):12843-7.
9778794	Benjamin S, Pandey A: Candida rugosa lipases: molecular biology and versatility in biotechnology. Yeast. 1998 Sep 15;14(12):1069-87.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3089

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
58551

# Drug_Target_2_Name:
Lipase 1

# Drug_Target_2_Number_of_Residues:
549

# Drug_Target_2_PDB_ID:
1LPS

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00135	COesterase

# Drug_Target_2_Protein_Sequence:
>Lipase 1 precursor
MELALALSLIASVAAAPTATLANGDTITGLNAIINEAFLGIPFAEPPVGNLRFKDPVPYS
GSLDGQKFTSYGPSCMQQNPEGTYEENLPKAALDLVMQSKVFEAVSPSSEDCLTINVVRP
PGTKAGANLPVMLWIFGGGFEVGGTSTFPPAQMITKSIAMGKPIIHVSVNYRVSSWGFLA
GDEIKAEGSANAGLKDQRLGMQWVADNIAAFGGDPTKVTIFGESAGSMSVMCHILWNDGD
NTYKGKPLFRAGIMQSGAMVPSDAVDGIYGNEIFDLLASNAGCGSASDKLACLRGVSSDT
LEDATNNTPGFLAYSSLRLSYLPRPDGVNITDDMYALVREGKYANIPVIIGDQNDEGTFF
GTSSLNVTTDAQAREYFKQSFVHASDAEIDTLMTAYPGDITQGSPFDTGILNALTPQFKR
ISAVLGDLGFTLARRYFLNHYTGGTKYSFLSKQLSGLPVLGTFHSNDIVFQDYLLGSGSL
IYNNAFIAFATDLDPNTAGLLVKWPEYTSSSQSGNNLMMINALGLYTGKDNFRTAGYDAL
FSNPPSFFV

# Drug_Target_2_Reaction:
triacylglycerol + H2O = diacylglycerol + a carboxylate

# Drug_Target_2_Signals:
1-15

# Drug_Target_2_Specific_Function:
Triacylglycerol + H(2)O = diacylglycerol + a carboxylate

# Drug_Target_2_SwissProt_ID:
P20261

# Drug_Target_2_SwissProt_Name:
LIP1_CANRU

# Drug_Target_2_Synonyms:
EC 3.1.1.3
Lipase 1 precursor

# Drug_Target_2_Theoretical_pI:
4.43

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02776
